Article
An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator.
The Journal of experimental medicine - 2 Jun 1997
Douhan J, Lieberson R, Knoll J H, Zhou H, Glimcher L H
Abstract excerpt
Patients with one type of major histocompatibility complex class II combined immunodeficiency have mutations in a gene termed class II transactivator (CIITA), which coordinately controls the transcription of the three major human class II genes, HLA-DR, -DQ, and -DP. However, the experimentally derived B-lymphoblastoid cell line, clone 13, expresses high levels of HLADQ in the absence of HLA-DR and HLA-DP,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
